Companies researching Opdivo (nivolumab)
Opdivo, known generically as nivolumab, is an immunotherapy medication employed to treat multiple forms of cancer.
13
companies
List of companies that research Opdivo (nivolumab)
| Company | Country | Industry | Employees | Revenue | Technologies |
|---|---|---|---|---|---|
United States | Pharmaceutical Manufacturing | 39k | $46B | Opdivo (nivolumab) | |
United States | Hospitals and Health Care | 1.4k | Opdivo (nivolumab) | ||
United States | Pharmaceutical Manufacturing | 3.4k | $15M | Opdivo (nivolumab) | |
United States | Business Consulting and Services | 1.2k | Opdivo (nivolumab) | ||
United States | Business Consulting and Services | 97 | $18M | Opdivo (nivolumab) | |
United States | Hospitals and Health Care | 21k | $5.5B | Opdivo (nivolumab) | |
France | Hospitals and Health Care | 3k | Opdivo (nivolumab) | ||
United States | Non-profit Organizations | 96 | Opdivo (nivolumab) | ||
United States | Medical Practices | 201 | $36M | Opdivo (nivolumab) | |
Netherlands | Research Services | 620 | Opdivo (nivolumab) |
Showing top companies out of 13 that research Opdivo (nivolumab). Get the full list on TheirStack.
Frequently asked questions






